ACR and infection: Since successful Acr-phage amplification relies on the strong production of Acrs at the onset of infection, we hypothesized that translation inhibitor antibiotics have the potential to interfere with Acr-induced immunosuppression, thereby effectively re-sensitizing the phage to full CRISPR-Cas immunity.